Compatible in Medical Technology

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

... ranges from 6-12 mm and lengths up to 120 mm. All stent sizes are compatible with 6F (2.1 mm) sheaths, and the stent delivery system is compatible with 0.035'' (0.89 mm) guidewires. The trial will enroll 123 patients ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... studied in patients with CHF. Exercise caution when using CIMZIA in patients who have heart failure and monitor them carefully. Symptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following ...

ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives

... allowing clinicians to automate the volume reduction steps and cryopreservation of processed bone marrow aspirates. The output of the MXP is compatible for stem cell cryopreservation using the ThermoGenesis BioArchive(R) System. A second initiative involves the use of the MXP to perform clinical ...

Gene Therapy Corrects Sickle Cell Disease in Laboratory Study

... marrow transplant to give recipients blood-forming cells that will form normal beta-globin. However, such transplants are rare because of the lack of compatible donors. Researchers have long known that symptoms of the disease could be alleviated by persistence in the blood of an immature fetal form ...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

... among 1,319 placebo-treated patients. The potential role of TNF blocker therapy in the development of malignancies is not known. Symptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following ...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

... among 1,319 placebo-treated patients. The potential role of TNF blocker therapy in the development of malignancies is not known. Symptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following ...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

... among 1,319 placebo-treated patients. The potential role of TNF blocker therapy in the development of malignancies is not known. Symptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following ...

Interface Biologics' Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings

... their products. Interface Biologics' Endexo(TM) anti-thrombic additives are non-drug polymers that have anti platelet properties. These polymers are compatible with a wide range of base polymers, and since they are an additive rather than a coating, afford ease of process manufacturing as well as provide ...

Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer

... prostate cancers. UNBS 5162 is a pan- antagonist of CXCL chemokines when administered in vitro chronically at 1 M, which is a drug concentration compatible with the doses used in vivo. The mode of action, as assessed by a National Cancer Institute comparative screen, appears to be unique. In an ...

JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures

... June 11 /PRNewswire-FirstCall/ -- JDSU today announced that its WaveReady 3000 series has been verified by Brocade Communications Systems Inc. as compatible with Brocade-based Storage Area Network (SAN) infrastructures according to the testing requirements of the Brocade Data Center Ready Program. The ...

Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease

... lymphoma among 1,319 placebo-treated patients. The potential role of TNF blocker therapy in the development of malignancies is not known. Symptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following ...

Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers

... oxygen-carrying red blood cell substitute. It is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit http://www.northfieldlabs.com . Forward Looking ...

Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development

... assays and research projects are based on recombinant cell lines. Optimizing such cell lines so they express a desired set of properties and are compatible with a particular screening platform takes considerable time and expense. Because of its ease and speed, transient transfection is increasingly used ...

Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases

... of perioperative FOLFOX4 in eligible metastatic colorectal patients with initially resectable liver metastases. Perioperative chemotherapy was found compatible with major liver surgery with operative mortality of less than one percent in both treatment arms." The most common adverse events seen with ...

A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds

... transplants that use bone marrow, umbilical cord blood, and peripheral blood from donors. The antigens on the surface of donated cells must be compatible (determined by a method called HLA matching) with those of the patient to prevent rejection. The use of embryonic stem cells, which have low levels ...

Improved Cornea Surgery Technique Provides Enhanced Transplant Success

... covering of the front of the eye that provides much of its optical power. When the cell density in the endothelial layer is reduced below a level compatible with its normal function, the cornea swells and becomes less transparent, and vision is impaired. Since endothelial cells do not regenerate, the ...

New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures

... The UEGW meeting is taking place in Paris October 27th - 31st . Cellvizio(R) GI is the first and only confocal endomicroscopy instrument that is compatible with all endoscopes and allows real-time, dynamic microscopic imaging of the entire GI tract at 12 frames per second. To date, more than 600 patients ...

Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned

... umbrella term used to describe a group of clinical diagnoses caused by narrowing of the coronary arteries and covers any group of clinical symptoms compatible with acute myocardial ischemia, caused by an imbalance between myocardial oxygen supply and demand from coronary artery disease. Unstable angina, ...

UCLA Program Aims to Revolutionize Kidney Transplants

... experts are studying a program they call "living donor swap." This program enables the relative or friend of a kidney-transplant patient who is not compatible as a donor to "swap" organs with another potential donor who also may be an incompatible match for his or her relative or friend. This greatly ...

New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace

... costs and save millions of lives. Novel new TB drugs also are needed to be compatible with antiretroviral drugs used to treat HIV for the rising number of those ... be effective against susceptible and resistant strains, be compatible with antiretroviral therapies for those HIV-TB patients currently on such ...

Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy

... available in both manual and automated forms. The automated form is compatible with the BioGenex i6000 system. Other tests, which can also be automated, ... DNA probes, which are visible on a fluorescent microscope. FISH is compatible with all kinds of tissue, whether fixed or not. Like IHC, FISH is also ...

Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease

... therapy in clinical cure, microbiological eradication, and overall therapeutic response rates. The safety profile of telavancin in these studies was compatible with treatment of patients with serious infections due to resistant bacteria. Astellas Pharma Ltd Lovett House, Lovett Road, ...

Northfield Laboratories Investor Update

... red blood cells are not available. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit www.northfieldlabs.com. Forward Looking Statement ...

Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study

... blood cells are not available. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is, therefore, compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit www.northfieldlabs.com. Forward Looking Statement ...

Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia

... which was 11.5 g/dL at baseline, was maintained within +/- 1.0 g/dL at the end of six months of treatment. Hematide was generally well tolerated and compatible with adverse events usually observed in patients with chronic kidney disease, with 6 percent of patients reporting adverse events possibly related to ...

Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.

... CYP450 Test. It includes a fluidics system, microarray scanner, workstation and software to carry out all of the steps outlined above. Other compatible products microarrays are expected in the future from Roche Diagnostics and its partner, Affymetrix. Companies such as Nanogen also continue to ...

Monitoring Patient Glucose Levels: New Advances in software make it easier

... obtaining printouts consists of simply plugging the glucose monitor into a cable, pushing a button, then waiting a few seconds. The Smart printer is compatible with the Accu-Chek Compact, the AccuSoft Advantage, the Accu-Chek Complete and the Accu-check Active blood glucose monitors as well as hand-held ....